Novartis Financial Results Q4 2023 – English
i note Novartis released results and not a single mention Locametz.
im thinking its just a complimentary product to Pluvicto (Pluvicto nearly a Billion in sales yearly), and its not actively pushed by Novartis
... good for Illuccix
Understanding Telix, page-349
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.69 |
Change
0.215(1.39%) |
Mkt cap ! $5.170B | |||
| Open | High | Low | Value | Volume |
| $15.40 | $15.83 | $15.40 | $3.670M | 235.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 193 | $15.68 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.69 | 578 | 5 |
View Market Depth
| Last trade - 12.06pm 29/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$15.58 |
Change
0.215 ( 0.38 %) |
||||
| Open | High | Low | Volume | ||
| $15.47 | $15.82 | $15.40 | 59035 | ||
| Last updated 12.24pm 29/05/2024 ? | |||||
| TLX (ASX) Chart |